Related Experiment Video
Updated: Jun 10, 2026

A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice
Published on: June 22, 2022
MELAS and L-arginine therapy: pathophysiology of stroke-like episodes
Yasutoshi Koga1, Nataliya Povalko, Junko Nishioka
1Department of Pediatrics and Child Health, Kurume University School of Medicine, Kurume, Fukuoka, Japan. yasukoga@med.kurume-u.ac.jp
Abstract:
Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) is a maternally inherited multisystem mitochondrial disorder. Although many molecular and cellular mechanisms have been discovered leading to mitochondrial cytopathy, the pathogenic mechanism of stroke-like episodes seen in MELAS has not been clarified yet. According to the muscle and brain pathology and vascular physiology, mitochondrial angiopathy, or endothelial dysfunction, were proposed to play an important role for developing stroke-like episodes. Based on a hypothesis of mitochondrial angiopathy theory, we use L-arginine in MELAS patients and report its usefulness. This review aims to give a general idea on the actual knowledge about the possible pathogenic mechanism of stroke-like episodes, including clinical symptoms that lead to stroke-like episodes, muscle, or brain pathology, molecular cellular functions, neuroimagings including MRI, MRS, and SPECT, and the proposed site of action of L-arginine therapy on MELAS patients. Currently, L-arginine therapy may be the most promising for the treatment of stroke-like episodes in MELAS.
Insights
Stroke-like episodes in MELAS patients may stem from mitochondrial angiopathy. L-arginine therapy shows promise for treating these episodes in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
Area of Science:
- Neurology
- Mitochondrial Diseases
- Vascular Biology
Background:
- Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) is a multisystem mitochondrial disorder with unclear stroke-like episode mechanisms.
- Mitochondrial angiopathy and endothelial dysfunction are hypothesized contributors to stroke-like episodes in MELAS.
Purpose of the Study:
- To review the current understanding of pathogenic mechanisms behind stroke-like episodes in MELAS.
- To explore the potential therapeutic role of L-arginine in managing MELAS-related stroke-like episodes.
Main Methods:
- Review of clinical symptoms, muscle/brain pathology, molecular functions, and neuroimaging (MRI, MRS, SPECT) in MELAS.
- Analysis of the proposed mechanism of action for L-arginine therapy in MELAS patients.
Main Results:
- The exact pathogenic mechanism of stroke-like episodes in MELAS remains under investigation.
- L-arginine therapy is proposed as a potentially beneficial treatment for stroke-like episodes in MELAS.
Conclusions:
- Mitochondrial angiopathy is a leading hypothesis for MELAS stroke-like episodes.
- L-arginine therapy presents a promising avenue for treating stroke-like episodes in MELAS patients.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Transient Ischemic Attack l: Introduction
Hemorrhagic Stroke l: Introduction
Atherosclerosis IV: Nursing Management

